Time-dependent differences of repeated administration with Δ9- tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate-putamen

Molecular Brain Research

Volumn 67, Issue 1, 1999, Pages 148-157

  Corchero, Javier ^a   Romero, Julian ^b   Berrendero, Fernando ^b   Fernandez Ruiz, Javier ^b   Ramos, José A ^b   Fuentes, José A ^a   Manzanares, Jorge ^a  

^a INSTITUTO PLURIDISCIPLINAR   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 Tetrahydrocannabinol; 35S GTP binding; Cannabinoid receptor; Caudate putamen; mRNA; Proenkephalin

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; DRONABINOL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; MU OPIATE RECEPTOR; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SIGNAL TRANSDUCTION; TIME;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; GENE EXPRESSION; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); IN SITU HYBRIDIZATION; MALE; MORPHOLINES; NAPHTHALENES; NEOSTRIATUM; PROTEIN PRECURSORS; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SULFUR RADIOISOTOPES; TETRAHYDROCANNABINOL; TIME FACTORS;

ANIMALIA;

EID: 0033528652     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00053-4     Document Type: Article

References (39)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain, Pharmacol. Biochem. Behav. 46 (1993) 575-579.
2. J.A. Angulo, B.S. McEwen, Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens, Brain Res. Rev. 19 (1994) 1-28.
3. C.S. Breivogel, D.E. Selley, S.R. Childers, Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes, J. Neurochem. 68 (1997) 1462-1472.
4. J. Corchero, J.A. Fuentes, J. Manzanares, Δ-9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus, Eur. J. Pharmacol. 323 (1997) 193-195.
5. J. Corchero, M.A. Avila, J.A. Fuentes, J. Manzanares, Δ-9-Tetrahydrocannabinol increases prodynorphin and preproenkephalin gene expression in the spinal cord of the rat, Life Sci. 61 (1997) PL39-PL43.
6. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, R.G. Stevenson, G. Griffin, D. Gibson, L.A. Mandelbaum, A. Etinger, R. Mechoulam, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258 (1992) 1946-1949.
7. W.L. Dewey, Cannabinoid pharmacology, Pharmacol. Rev. 38 (1986) 151-178.
8. C.M. Gerard, C. Mollereaux, G. Vassart, M. Parmentier, Molecular cloning of a human cannabinoid receptor which is also expressed in testis, Biochem. J. 279 (1991) 129-134.
9. R.E. Harlan, B.D. Shivers, G.J. Romano, R.D. Howells, D.W. Pfaff, Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization, J. Comp. Neurol. 258 (1987) 159-184.
10. T. Kenakin, Efficacy, in: T. Kenakin (Ed.), Pharmacologic Analysis of Drug-Receptor Interaction, Raven Press, New York, 1993, pp. 249-277.
11. 9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain, Brain Res. 525 (1990) 78-83.
12. P. Mailleux, J.J. Vanderhaegen, Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding autoradiography and in situ hybridization histochemistry, Neuroscience 48 (1992) 655-668.
13. P. Mailleux, J.J. Vanderhaeghen, δ-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen, Eur. J. Pharmacol. 267 (1994) R1-R3.
14. Y.P. Maneuf, A.R. Crossman, J. Brotchie, Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN-55,212-2, Synapse 4 (1996) 382-385.
15. A. Mansour, C.A. Fox, H. Akil, S.J. Watson, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends Neurosci. 18 (1995) 22-29.
16. J. Manzanares, J. Corchero, J. Romero, J.J. Fernández-Ruiz, J.A. Ramos, J.A. Fuentes, Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain, Mol. Brain Res. 55 (1998) 126-132.
17. L.A. Matsuda, S.J. Lolait, M.J. Browstein, A.C. Young, T.I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346 (1990) 561-564.
18. L.A. Matsuda, T.I. Bonner, S.J. Lolait, Localization of cannabinoid receptor mRNA in rat brain, J. Comp. Neurol. 327 (1993) 535-550.
19. S. Munro, K.L. Thomas, M. Au-Shaar, Molecular characterization of a peripheral receptor for cannabinoids, Nature 365 (1993) 61-65.
20. A. Oviedo, J. Glowa, M. Herkenham, Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study, Brain Res. 616 (1993) 293-302.
21. G. Pugh Jr., D.J. Mason Jr., V. Combs, S.P. Welch, Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP-55,940 in the spinal cord, J. Pharmacol. Exp. Ther. 281 (1997) 730-737.
22. 9-tetrahydrocannabinol-induced analgesia in mice, Eur. J. Pharmacol. 301 (1996) 75-81.
23. 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors, Eur. J. Pharmacol. 318 (1996) 11-16.
24. 9-tetrahydrocannabinol-induced antinociception in mice, Neuropharmacology 37 (1998) 215-222.
25. 9-tetrahydrocannabinol treatment, Pharmacol. Biochem. Behav. 47 (1994) 33-40.
26. J. Romero, L. García, M. Cebeira, D. Zadrozny, J.J. Fernández-Ruiz, J.A. Ramos, The endogenous cannabinoid ligand, anandamide, inhibits the motor behaviour: role of a nigrostriatal dopaminergic neurons, Life Sci. 56 (1995) 2033-2040.
27. J. Romero, E. García-Palomero, J.J. Fernandez-Ruiz, J.A. Ramos, Involvement of GABA-B receptors in the motor inhibition produced by agonist of brain cannabinoid receptors, Behav. Pharmacol. 7 (1996) 299-302.
28. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions, Mol. Brain Res. 46 (1997) 100-108.
29. 9-tetrahydrocannabinol, Synapse 30 (1998) 298-308.
30. 9-tetrahydrocannabinol, J. Mol. Neurosci., in press.
31. T. Rubino, P. Massi, G. Patrini, I. Venier, G. Giagnoni, D. Parolaro, Chronic CP-55,940 alters cannabinoid receptor-mRNA in the rat brain: an in situ hybridization study, NeuroReport 5 (1994) 2493-2496.
32. 35S]thio]-triphosphate binding, P.N.A.S. USA 92 (1995) 7242-7246.
33. 35S]GTPγS autoradiography in rat brain, J. Neurosci. 16 (1996) 8057-8066.
34. N. Stella, P. Schweitzer, D. Piomelli, A second endogenous cannabinoid that modulates long-term potentiation, Nature 388 (1997) 773-778.
35. G. Vela, M. Ruiz-Gayo, J.A. Fuentes, Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine, Neuropharmacology 34 (1995) 665-668.
36. S.P. Welch, Blockade of cannabinoid induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-Phenylalanine-leucine, ICI 174,864 or naloxone in mice, J. Pharmacol. Exp. Ther. 265 (1993) 633-640.
37. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors, Brain Res. 544 (1991) 145-149.
38. S. Young III, T. Bonner, M. Brann, Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. USA 83 (1986) 9827-9831.
39. 9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions, Mol. Brain Res. 62 (1998) 141-149.